Not sure where to start? Try searching for your diagnosis above or visit the "Conditions" section.
Autoimmune Archive is a curated library of research, news, and resources for people living with autoimmune diseases. We track the latest studies, organize information by condition, and cut through the noise so you can spend less time searching and more time focused on your health.
Use the search bar above to find information about your diagnosis, browse the Conditions section for condition-specific resources, or explore the Library for the latest research and news. If you know of an article or resource that belongs here, we'd love to hear about it — use the Suggest a Resource link above to submit it for review.
Discover what's on this website and how to best use it.
Learn about autoimmune diseases, their symptoms, treatments, prognosis, and more.
Tools and resources to help you learn about your autoimmune disease and manage it.
Researchers in Barcelona have designed a molecule called celiacase that breaks down the most harmful gluten fragments inside the stomach, before they reach the small intestine and...
Read More — A Lab-Engineered Molecule Named Celiacase Could Change How Celiac Disease Is Managed »Phase 3 data presented at AAN 2026 show that IVIG significantly improves response rates in autoimmune encephalitis patients who do not respond to corticosteroids alone.
Read More — New Phase 3 Trial Data Show IVIG Improves Outcomes in Autoimmune Encephalitis »A new study of 371 autoimmune hepatitis patients found nearly 24 percent also had extrahepatic autoimmune diseases, most commonly Sjogren's syndrome and autoimmune thyroid disease,...
Read More — Nearly One in Four Autoimmune Hepatitis Patients Also Has Another Autoimmune Disease, Study Finds »Extended treatment with Nektar Therapeutics' rezpegaldesleukin produced clinically meaningful hair regrowth in 27% of participants with severe alopecia areata at one year, with Nek...
Read More — Rezpeg Produces Meaningful Hair Regrowth at One Year in Severe Alopecia Areata, Phase 3 Plans Announced »FDA fast track designation highlights potential new cell therapy for autoimmune diseases.
Read More — FDA Grants Fast Track Status to Allogene’s Autoimmune Therapy »Updated results from UChicago Medicine show that all 10 evaluable patients who received islet transplants supported by tegoprubart achieved insulin independence with near-normal bl...
Read More — All 10 Evaluable Patients Achieve Insulin Independence in Eledon's Type 1 Diabetes Islet Transplant Trial »
Blog
Managing Hashimoto's thyroiditis often feels like assembling a puzzle with too many pieces. Thyroid medication is typically the foundation of treatment, but many patients continue...
Read More — Best Supplements for Hashimoto's Thyroiditis: What the Evidence Actually Says »
Blog
Fifteen minutes is not a lot of time, especially when you're managing a complex chronic illness with multiple symptoms, multiple medications, and a list of questions that has been...
Read More — How to Get the Most Out of a 15-Minute Doctor's Appointment With a Chronic Illness »
Blog
The word "flare" gets used constantly in autoimmune communities, but it rarely gets a clear definition. If you've been told your disease is flaring, or if you suspect one is starti...
Read More — What Is a Flare, Really? »A critical appraisal of a large cohort study finds that neurological complications in dermatitis herpetiformis are likely significantly undercounted because standard registry codes...
Read More — Neurological Complications in Dermatitis Herpetiformis May Be Underestimated by Standard Registry Data »A new clinical tool developed from a four-hospital Chinese study can predict survival outcomes in patients with MDA5-positive dermatomyositis who also have interstitial lung diseas...
Read More — Multicenter Study Develops Prognostic Nomogram for MDA5-Positive Dermatomyositis with Lung Disease »A landmark phase 3 trial has found that brepocitinib, an oral TYK2/JAK1 inhibitor, significantly improved a comprehensive measure of disease activity in adults with dermatomyositis...
Read More — Brepocitinib Achieves First Positive Phase 3 Trial Result in Dermatomyositis: The VALOR Study »A new review clarifies how the type of antibody driving cicatricial pemphigoid and related subepidermal blistering diseases influences both what the condition looks like and how it...
Read More — Antibody Class and Target Shape Disease Phenotype and Treatment in Cicatricial Pemphigoid and Related Conditions »A 2026 clinical practice review in the New England Journal of Medicine offers a comprehensive update on how to diagnose and manage polymyalgia rheumatica, the inflammatory conditio...
Read More — NEJM Clinical Practice Review: Polymyalgia Rheumatica Diagnosis and Management in Adults Over 50 »A landmark phase 3 trial found that obinutuzumab, a targeted anti-CD20 antibody, significantly outperformed placebo in reducing disease activity in people with active systemic lupu...
Read More — Obinutuzumab Achieves Superior Disease Control in Phase 3 ALLEGORY Trial for Systemic Lupus Erythematosus »
